HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Hwa Lee Selected Research

PD 173074

1/2020Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer.
10/2018The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei-Hwa Lee Research Topics

Disease

47Neoplasms (Cancer)
06/2022 - 04/2003
10Neoplasm Metastasis (Metastasis)
01/2022 - 07/2013
10Hepatocellular Carcinoma (Hepatoma)
06/2021 - 01/2013
10Carcinogenesis
06/2021 - 07/2013
6Glioma (Gliomas)
08/2021 - 12/2009
6Breast Neoplasms (Breast Cancer)
01/2019 - 07/2013
5Squamous Cell Carcinoma of Head and Neck
01/2022 - 11/2015
5Colorectal Neoplasms (Colorectal Cancer)
08/2018 - 01/2006
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2013
4Adenocarcinoma
01/2020 - 01/2006
4Glioblastoma (Glioblastoma Multiforme)
12/2018 - 05/2015
3Inflammation (Inflammations)
10/2021 - 12/2005
3Liver Neoplasms (Liver Cancer)
06/2021 - 01/2018
3Ovarian Neoplasms (Ovarian Cancer)
05/2017 - 05/2015
2Osteoarthritis
06/2022 - 10/2021
2Lung Neoplasms (Lung Cancer)
01/2019 - 12/2013
2Disease Progression
09/2018 - 02/2016
2Carcinoma (Carcinomatosis)
09/2018 - 05/2006
2Adenocarcinoma of Lung
01/2018 - 01/2018
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 01/2014
2Hyperglycemia
03/2015 - 12/2011
2Type 2 Diabetes Mellitus (MODY)
03/2015 - 12/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2022
1Arthritis (Polyarthritis)
10/2021
1Hypertrophy
10/2021
1Acquired Immunodeficiency Syndrome (AIDS)
06/2021
1Virus Diseases (Viral Diseases)
06/2021
1Plasmacytoma
01/2021
1Colonic Neoplasms (Colon Cancer)
01/2021
1Gliosarcoma
05/2020
1Hypoxia (Hypoxemia)
01/2020
1Esophageal Neoplasms (Esophageal Cancer)
12/2019
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
03/2019

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
06/2021 - 01/2006
6Pharmaceutical PreparationsIBA
01/2022 - 06/2015
6Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2015
6CateninsIBA
01/2020 - 01/2013
6MicroRNAs (MicroRNA)IBA
08/2018 - 07/2013
5Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2018
4Biological ProductsIBA
01/2021 - 01/2006
4pterostilbeneIBA
06/2015 - 01/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 01/2006
3ovatodiolideIBA
03/2019 - 01/2018
34-acetylantroquinonol BIBA
12/2018 - 10/2015
3Tyrosine Kinase InhibitorsIBA
01/2018 - 01/2018
3Histone DemethylasesIBA
01/2018 - 01/2015
3Glucose (Dextrose)FDA LinkGeneric
09/2016 - 12/2011
2AntioxidantsIBA
01/2022 - 07/2017
2CytokinesIBA
10/2021 - 02/2014
2Therapeutic UsesIBA
10/2021 - 11/2015
2Sorafenib (BAY 43-9006)FDA Link
06/2021 - 06/2021
2Agammaglobulinaemia Tyrosine KinaseIBA
02/2021 - 05/2015
2Long Noncoding RNAIBA
01/2021 - 02/2016
2VimentinIBA
01/2021 - 12/2019
2PD 173074IBA
01/2020 - 10/2018
2Caspase 3 (Caspase-3)IBA
01/2020 - 10/2018
2CollagenIBA
06/2019 - 12/2005
2Messenger RNA (mRNA)IBA
01/2019 - 09/2016
2Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 01/2014
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
09/2016 - 03/2015
2Streptozocin (Streptozotocin)FDA Link
03/2015 - 12/2011
2osthol (osthole)IBA
03/2015 - 12/2011
2ErbB Receptors (EGF Receptor)IBA
12/2013 - 01/2006
2LipidsIBA
12/2011 - 01/2006
2Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
05/2006 - 01/2006
2Metalloproteases (Metalloproteinases)IBA
05/2006 - 01/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2022
1Growth Differentiation Factor 15IBA
06/2022
1Mitogen-Activated Protein Kinase 14IBA
06/2022
1human ERBB2 proteinIBA
01/2022
1PlatinumIBA
01/2022
1CalcineurinIBA
01/2022
1BX795IBA
10/2021
1Janus Kinase InhibitorsIBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021
1tofacitinibIBA
10/2021
1acalabrutinibIBA
08/2021
1Sirolimus (Rapamycin)FDA Link
08/2021
1Beclin-1IBA
06/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
06/2021
1N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
06/2021
1EnzymesIBA
01/2021
1Protons (Proton)IBA
05/2020
1Firefly LuciferasesIBA
01/2020
1Untranslated RNA (Noncoding RNA)IBA
01/2020
1fatostatinIBA
12/2019
1Sterol Regulatory Element Binding Protein 1IBA
12/2019
1Cadherins (E-Cadherin)IBA
12/2019
1alpha2 Subunit Collagen Type IIBA
06/2019
1Estrogens (Estrogen)FDA Link
01/2019
1Amino AcidsFDA Link
01/2019
1IsotopesIBA
01/2019

Therapy/Procedure

13Therapeutics
10/2021 - 12/2013
9Drug Therapy (Chemotherapy)
01/2022 - 04/2003
4Radiotherapy
01/2020 - 01/2013
1Intra-Articular Injections
10/2021
1Chemoradiotherapy
02/2021
1Aftercare (After-Treatment)
05/2020
1Craniotomy
05/2020